A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Participants will have a confirmed diagnosis of metastatic breast cancer and will receive pembrolizumab in combination with cryoablation OR pembrolizumab alone. Participants will be randomly assigned.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek od 18 lat
- •Potwierdzony przerzutowy rak piersi typu potrójnie ujemnego
- •Co najmniej jedno ognisko (≥1,5 cm) możliwe do kriolacji
- •Zdolność fizyczna do poddania się zabiegowi kriolacji
- •Zgoda na antykoncepcję podczas leczenia pembrolizumabem
- •Planowane leczenie pembrolizumabem jako pierwsza, druga lub trzecia linia terapii
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- May 20, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (7)
Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities)
Basking Ridge, United States
Memorial Sloan Kettering Monmouth (Limited protocol activities)
Middletown, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, United States
Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities )
Commack, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, United States
Memorial Sloan Kettering Cancer Center (All protocol activites)
New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activites)
Rockville Centre, United States
Trial contact
Yolanda Bryce, MD
Larry Norton, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.